Cargando…

Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

The role of cystatin C (Cys-C) in tumorigenesis and progression of bladder urothelial tumors (BUT) is still indefinite. We retrospectively collected the clinical information from the records of 425 BUT patients. Pretreatment serum Cys-C levels were compared across the various groups. Then we subgrou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hui, Gao, Lijian, Meng, Cuiyu, Yu, Nengwang, Yang, Feilong, Zhang, Cong, Li, Dawei, Yan, Lei, Liu, Hainan, Xu, Zhonghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896344/ https://www.ncbi.nlm.nih.gov/pubmed/29789781 http://dx.doi.org/10.1155/2018/2617439

Ejemplares similares

Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia
por: Yang, Feilong, et al.
Publicado: (2017)

Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway
por: Zhang, Cong, et al.
Publicado: (2019)

Elevated Serum Sialic Acid Levels Predict Prostate Cancer As Well As Bone Metastases
por: Zhang, Cong, et al.
Publicado: (2019)

Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9
por: Yang, Feilong, et al.
Publicado: (2018)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Cystatin C as a Promising Biomarker of Atherosclerotic Plaque
por: Sawada, Shojiro
Publicado: (2021)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of Ephrin A3 in bladder urothelial carcinoma
por: Wang, Yi-Fan, et al.
Publicado: (2023)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma
por: Tan, Ping, et al.
Publicado: (2019)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis
por: Jin, Di, et al.
Publicado: (2020)

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
por: Valdés, Alberto, et al.
Publicado: (2021)

Epigenetic inactivation of DNA repair genes as promising prognostic and predictive biomarkers in urothelial bladder carcinoma patients
por: Mohanad, Marwa, et al.
Publicado: (2022)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

Predictive Value of Clinicopathological Markers for the Metachronous Bladder Cancer and Prognosis of Upper Tract Urothelial Carcinoma
por: Feng, Chenchen, et al.
Publicado: (2014)

Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder
por: Mumtaz, Shazia, et al.
Publicado: (2020)

Proteomic analyses reveal cystatin c is a promising biomarker for evaluation of systemic lupus erythematosus
por: Huang, He, et al.
Publicado: (2023)

ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
por: Mori, Keiichiro, et al.
Publicado: (2022)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics
por: Hung, Sheng-Chun, et al.
Publicado: (2018)

Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma
por: Guo, Shengjie, et al.
Publicado: (2017)

Clinicopathological Significance of Estrogen Receptor β and Estrogen Synthesizing/Metabolizing Enzymes in Urothelial Carcinoma of Urinary Bladder
por: Sato, Naomi, et al.
Publicado: (2021)

Serum Cystatin C as a Biomarker for Predicting Coronary Artery Disease in Diabetes
por: Oh, Jee-Young
Publicado: (2010)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Hammouda, Nada E., et al.
Publicado: (2017)

Impact of age and gender on the clinicopathological characteristics of bladder cancer
por: Gupta, Parag, et al.
Publicado: (2009)

Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes
por: Gu, Liangyou, et al.
Publicado: (2020)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
por: Ravanini, Juliana Naves, et al.
Publicado: (2021)

Clinicopathological significance of cystatin A expression in progression of esophageal squamous cell carcinoma
por: Shiba, Daiki, et al.
Publicado: (2018)

Utility of cystatin C as a potential bladder tumour biomarker confirmed by surface plasmon resonance technique
por: Tokarzewicz, Anna, et al.
Publicado: (2018)

Serum cystatin C and CRP are early predictive biomarkers for emergence of hypoxia in COVID-19
por: Miyata, Yoshito, et al.
Publicado: (2022)

Serum cystatin C is an early renal dysfunction biomarker in patients with hepatitis C virus
por: Assem, Nagwa Mohamed, et al.
Publicado: (2022)

Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer
por: Tschui, J., et al.
Publicado: (2015)

Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
por: Yang, Li, et al.
Publicado: (2021)

Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan
por: Wang, Shian-Shiang, et al.
Publicado: (2013)

Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas
por: Shang, Zhi, et al.
Publicado: (2022)

Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma
por: Weng, Wei-Chun, et al.
Publicado: (2023)

The impacts of MACC1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan
por: Chang, Li-Wen, et al.
Publicado: (2023)

Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model
por: Su, Qiongli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cihju94t8headorp1rr6nfaqfl